GTCR Pharma Platform Adds On
Actient Pharmaceuticals Inc., a Denver-based specialty pharma acquisition platform sponsored by GTCR, has acquired six on-marketl products from a subsidiary of Belgium's UCB SA. No financial terms were disclosed.
Actient Pharmaceuticals Inc., a Denver-based specialty pharma acquisition platform sponsored by GTCR, has acquired six on-marketl products from a subsidiary of Belgium's UCB SA. No financial terms were disclosed.